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It is assumed that DNA sequences are conserved in the diverse cell types present in a
multicellular organism like the human being. Thus, in order to compare the sequences in
the genome of DNA from different individuals, nucleic acid is commonly isolated from
a single tissue. In this regard, blood cells are widely used for this purpose because
of their availability. Thus blood DNA has been used to study genetic familiar diseases
that affect other tissues and organs, such as the liver, heart, and brain. While this
approach is valid for the identification of familial diseases in which mutations are present
in parental germinal cells and, therefore, in all the cells of a given organism, it is
not suitable to identify sporadic diseases in which mutations might occur in specific
somatic cells. This review addresses somatic DNA variations in different tissues or cells
(mainly in the brain) of single individuals and discusses whether the dogma of DNA
invariance between cell types is indeed correct. We will also discuss how single nucleotide
somatic variations arise, focusing on the presence of specific DNA mutations in the
brain.
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INTRODUCTION
DNA molecules have been described as the conserved stores of
genetic information (Cech, 2012). Whole-genome and exome
sequencing are powerful research tools with which to analyze
the molecular basis of many human diseases of familial origin
(Drmanac, 2012). However, during development or in adulthood,
somatic mutations may appear in specific tissues of a human
being (or other organism).
With the sequencing data in hand, the bottleneck lies in the
bioinformatic analysis (Brunham and Hayden, 2012) required
Glossary: De novo mutation: new mutation. Alteration in a gene that appears
for the first time in a member of a family as a result of a mutation produced
in a germ cell (egg or sperm) or in the fertilized egg. Germinal mutation:
mutation that occurs in a germ cell (egg or sperm) and can be transmitted to
the offspring. Somatic mutation: mutation that is not inherited from parents
and not transferred to the offspring. They can occur in any of the cells except
the germ cells. Exome: part of the genome composed by the exons, the portions
of the genes containing the information to synthesize the proteins. Mosaicism:
it describes a condition in which one individual who has developed from
a single fertilized egg, has two or more populations of cells with different
genotypes. If these different populations of cells are in a somatic tissue, we
talk about somatic mosaicism. We refer to germline mosaicism when some
gametes (oocytes or sperm) carry a mutation in an individual cell, but the rest
of cells are normal.
to obtain reliable results (it has been reported that whole-
genome sequencing technology has an accuracy of only one
false single nucleotide variation per 500 kbp (Roach et al.,
2011)).
High-throughput sequencing technologies, like those
from Illumina Life Technologies, Ion Torrent, and Roche
Diagnostics, are widely used. Other sequence detection
methods are based on magnetic tweezers (Linnarsson, 2012)
or on other approaches, such as nanopore sequencing
analysis, in which single molecules of DNA can be
deciphered as they pass through a tiny channel (Pennisi,
2012). All these techniques have facilitated whole-genome
or exome sequencing at an unprecedented scale, thus
allowing the launch of initiatives such as the 1000 Genomes
Project, which seeks to analyze DNA variations in human
populations (Clarke et al., 2012). It has been suggested
that each genome contains 1.5 105 new single nucleotide
variants (SNVs) that are not present in the dbSNP database
(Pelak et al., 2010). These variants are present in different
genome regions, like the exome, and may be related to
genes involved in human diseases (MacArthur et al.,
2012).
In this review, we will comment on somatic DNA mutations
occurring mainly in the brain.
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HOW TO OBTAIN RELIABLE DATA IN GENOME (EXOME)
SEQUENCING
Sequence analysis can be done from homogeneous (from a
single cell type) or heterogeneous DNA samples. In the first
case, Sanger’s method may still be the most accurate analy-
sis to obtain reliable results. However, samples containing het-
erogeneous (more than five types) DNA molecules cannot be
sequenced by this technique, thus requiring alternative methods
like Illumina sequencing. However, these massive sequencing
techniques can generate artifacts. A preliminary approach to
identify these artifacts is through examining the genome database
to determine whether an identified variant is already present
(thus suggesting that is not an artifact). Another approach, based
on the old idea that the DNA sequence in a single organism
is identical in every cell of the organism, is to look for pos-
sible Mendelian errors. To distinguish false from true variants
in the genome of a human being, the sequences of the DNA
of his/her parents will indicate the presence of a new variant
present in the child but that is absent in the parents. This
Mendelian error may suggest a false variant when somatic muta-
tions are not taken into account (Patel et al., 2014). However,
this possible false variant may also originate from a somatic
mutation occurring specifically in the DNA of the child. This
issue can be addressed by obtaining 50–200 reads of each base
to confirm the presence of a SNV. Nevertheless, it cannot be
concluded that a variant found only at low number of reads is
not a true variant. When a heterogeneous sample contains more
than one cell type, the difference among the proportion of DNA
molecules containing a variant correlates with the proportion
of cells in which these molecules are present. If the change in
sequence in the somatic cells took place during development,
more cells are likely to contain this variation. However, if the
change occurred late in adult life, only a small proportion of
the cells will hold the DNA modification. It may be difficult to
validate such DNA somatic sequences by methods other than
those of Illumina. This is a limitation of current next-generation
sequencing techniques, which have the sensitivity required for the
analysis of heterogeneous DNA samples but generate an (low)
error rate.
SOMATIC DNA MUTATIONS
The development of a human starts from one cell that divides
into two, followed by further cell divisions until the organism
has generated more than 1013 cells in a precisely controlled
ontogenetic process (Frank, 2010). During development, fail-
ures in DNA replication (or repair) during cell proliferation
may occur and result in the appearance of somatic mutations.
Afterwards, during adulthood, additional somatic mutations may
arise, and genomic variability may encode distinct cell lineages
in different tissues (Frumkin et al., 2005). In fact, studies have
pointed to the presence of multiple different genomes in a
single human being (Lupski, 2013), and differences in DNA
sequences have been reported in a variety of tissues (Frank,
2010; Pelak et al., 2010; Clarke et al., 2012; MacArthur et al.,
2012; Pennisi, 2012) from the same individual. Depending on
the circumstances, the appearance of somatic mutations differs
depending on the tissue type. One of these circumstances is the
presence of distinct types and amounts of DNA polymerases
or repair enzymes in tissues. Low fidelity DNA polymerases
can introduce not only nucleotide substitutions but also tan-
dem mutations, as is the case of DNA polymerase ζ (Saribasak
et al., 2012). Various forms of mutations may arise, such as
sense and non-sense base substitutions (SNP), deletions, and
insertions or through other mechanisms like the movement of
transportable elements (Lynch, 2010; Vogel, 2011). These vari-
ations could change depending on the cell origin. Moreover,
some types of cell are more sensitive to DNA damage or changes
than others. This is reflected by germinal and somatic cells. The
protection of the genome is critical for germ line development.
A mechanism to ensure this protection has been described in
Drosophila (Rangan et al., 2011). This mechanism does not act
on somatic cells and consequently this cell type is more sus-
ceptible to mutations. However, to facilitate genome mainte-
nance, in response to DNA damaging agents somatic cells have
a DNA-damage checkpoint-signaling pathway involving DNA-
repair scaffolding proteins like SlX4 (Ohouo et al., 2013). More-
over, specific double breaks are essential for the proper function
of specific cells, like sperm cells, because these DNA breaks
are required for the correct exchange of DNA (Kauppi et al.,
2013).
At the cellular level, considerable efforts have been devoted
to minimizing genomic insults in cultured pluripotent stem cells
(Weissbein et al., 2014). Additionally, in the whole organism,
clonal mosaicism for large chromosomal anomalies, from birth to
old age, has been reported (Jacobs et al., 2012; Laurie et al., 2012).
At cell cycle level, differences in DNA repair between the phases
of the cycle have been described. For instance, during mitosis,
DNA double-strand breaks (DSBs) are not repaired. It has been
suggested that these mitotic DBSs cause end to end chromosome
fusions and that they promote aberrant chromosome segregation
(Orthwein et al., 2014).
Also, at the molecular level, not all the bases in the human
genome are equally prone to chance mutations (Ponting, 2012).
Mutations are more frequently observed in three types of
sequences, namely simple repeats, DNAse hypersensitive sites
in embryonic stem cells, and some trinucleotide sequences
(Michaelson et al., 2012). Also, the expansion of trinucleotide
repeats causes some disorders, mainly in neurons and myopathies,
which could be caused by a slippage that involves DNA
polymerases β and δ (Chan et al., 2013). In contrast, for
some cells, like neuroblastoma cells, sensitivity to DNA dam-
age depends on their state of differentiation. Undifferentiated
human SH-SY5Y neuroblastoma cells are less sensitive to DNA
damage than differentiated cells, in part because they show
more efficient base excision repair mechanisms (Sykora et al.,
2013).
SOMATIC DNA MUTATION WITH AGING
Some tissues show an increased rate of DNA mutations with aging
(Kong et al., 2012). The appearance of somatic mutations, which
increases with age, is known to cause or increase susceptibility to
diseases like cancer (Moskalev et al., 2012). For example, an age
effect on the repair of DNA strand breaks in blood mononuclear
cells has been reported (Garm et al., 2013). Aging is also proposed
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to be a risk factor for neurodegenerative disorders. Indeed, an
increasing number of somatic mutations are being associated with
neurological diseases (Poduri et al., 2013; Madabhushi et al., 2014;
Singleton, 2014).
Furthermore, specific changes in mitochondrial brain DNA
have been reported (Bender et al., 2006; Kraytsberg et al.,
2006). Mitochondrial DNA (mtDNA) is not protected by his-
tones and is therefore more sensitive to external damage. Indeed,
mtDNA deletions are abundant in aged substantia nigra neu-
rons (Bender et al., 2006; Kraytsberg et al., 2006) and in
peripheral tissues (Baines et al., 2014). Curiously, mtDNA dam-
age in a mouse model of Alzheimer disease (AD) decreases
amyloid beta plaque formation (Pinto et al., 2013). More-
over, DNA ligase activity, which is probably involved in DNA
repair, is lower in mitochondrial extracts from AD patients
than in matched non-demented controls (Canugovi et al.,
2014).
MECHANISMS FOR DNA SEQUENCE VARIATIONS
Briefly, we will comment on several mechanisms that can give rise
to somatic DNA sequence variations. As mentioned, not all the
nucleotides in the human genome are equally prone to chance
mutations, with exonic sequences and GpG-rich sequences show-
ing greater susceptibility (Michaelson et al., 2012). CpG-rich
sequences can also be methylated (or demethylated), and such
changes in methylation in neurons affect memory formation
(Kaas et al., 2013).
Furthermore, CpG-rich sequences are present in the
promoters involved in divergent (on both sides with opposite
orientations) transcription. Changes in such sequences may alter
gene expression (Wu and Sharp, 2013).
Opening of the double helix facilitates DNA damage. This
opening occurs not only during DNA replication, a process in
which lesions may occur anywhere in the genome, but also during
the active transcription of regions. High levels of transcription
induce genomic instability (Wu and Sharp, 2013). A mouse model
deficient in DNA repair and transcription shows an increase
in DNA damage, which results in premature aging (de Boer
et al., 2002). This observation suggests that the opening of the
DNA double helix during DNA transcription also facilitates DNA
damage, as proposed for replication (Marchesi, 2011). Indeed,
during transcription, the coding DNA strand is exposed as a
single DNA strand, whereas the non-coding strand is base-
paired and protected by the nascent RNA (Aguilera and García-
Muse, 2012; Wu and Sharp, 2013). Also, the unwinding of the
DNA helix during transcription sometimes generates topological
perturbations that can affect genome stability (Bermejo et al.,
2012). In addition, somatic hypermutation of immunoglobu-
lin genes has been related to changes in RNA polymerase II
progression (Kodgire et al., 2013). Also, it has been described
that RNA polymerase and the protein UvrD, a helicase, coop-
erate to target a damaged DNA site for repair (Epshtein et al.,
2014).
DNA DAMAGE REPAIR MECHANISMS
There are several DNA damage repair mechanisms, these
involving base or nucleotide excision repair, mismatch repair,
non-homologous end joining or homologous recombination. In
base excision repair, it has been proposed that damaged DNA
bases are removed through a major pathway involving DNA
glycosylases (Caldecott, 2003; Jackson and Bartek, 2009). For
example, 7,8-dihydro-8-oxoguanine (8-OHdG), which arises by
oxidative damage, is hydrolyzed by MuTYH DNA glycosylases
(Markkanen et al., 2013). Also, Nei13 DNA glycosylase may
participate in this pathway (Regnell et al., 2012). Recently, the
effects of DNA sequence context on the glycosylase activity of
human 8-oxoguanine DNA glycosylase have been reported (Sassa
et al., 2012).
In addition, the modified base can be identified by a DNA
glycosylase and removed by an endonuclease, resulting in a gap
in the DNA sequence that is filled by a DNA polymerase and
sealed by a DNA ligase (Caldecott, 2003; Maiti et al., 2012).
When this repair mechanism is not working properly, the DNA
sequence undergoes a mutation (see also Deng et al., 2014) for
other repair mechanisms that can result in the introduction of
mutations into the genome). The probability of the appearance
of a mutation increases in the aged brain when there is an accu-
mulation of 8-OHdG (Wolf et al., 2005). It should be noted that
some DNA glycosylases involved in base excision repair contain
a Fe-S cluster essential for their activity (Cunningham et al.,
1989). Furthermore, oxidative damage specifically in neuronal
DNA can also occur. Indeed, the brain has an enhanced cellular
metabolism compared to other tissues, and this may result in the
formation of free radicals that damage the DNA of brain cells
(Hofman, 1991). In this regard, impaired repair of oxidative DNA
damage may influence the clinical manifestation of AD (Silva
et al., 2014).
Also, the deregulation of the DNA damage response has been
described upon intercellular contact in non-neuronal cells (Kang
et al., 2012). Nothing is known about whether synaptic neu-
ronal activity facilitates the deregulation of DNA damage. Also,
it has been established that ribonucleotides contaminate DNA
in some circumstances. Okazaki fragments play an important
role in replication. These fragments consist of a short sequence
of about 10 ribonucleotides followed by a sequence (about 300
nucleotides) of deoxyribonucleotides. The ribonucleotides must
be removed and replaced by deoxyribonucleotides during DNA
replication, but if complete removal is impaired, ribonucleotides
can be incorporated into nascent DNA. This aberrant incorpora-
tion results in DNA damage (Caldecott, 2014), directly or through
the formation of DNA single-strand breaks (SSBs), which in
turn have been linked to neurodegeneration (Caldecott, 2008). In
some conditions, like when the number of rNTPs exceeds that of
dNTPs, replicative DNA polymerases incorporate ribonucleotides
into DNA (Reijns et al., 2011). This aberrant incorporation can
be repaired by enzymatic removal of ribonucleotides from DNA,
to preserve genome integrity (Reijns et al., 2012). A mammalian
RNAse, RNAse H2, removes ribonucleotides from DNA to main-
tain genome integrity (Hiller et al., 2012). Also, the structural
localization of DNA lesions in nucleosome core particles influ-
ences accessibility to base excision repair enzymes (Rodriguez and
Smerdon, 2013). In addition, it is postulated that the histone mark
H3K36me3 regulates human DNA mismatch repair (Li et al.,
2013).
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As previously indicated, DNA damage can result in SSBs or
DSBs. When occurring in non-dividing cells, such as neurons,
these breaks promote premature aging of the cell (Ames et al.,
1993), thereby accelerating their demise. The repair of SSBs or
DSBs has been extensively reviewed (Ciccia and Elledge, 2010).
Single nucleotide excision repair can take place anywhere in the
genome (Ciccia and Elledge, 2010), even in actively transcribing
regions, as the transcribing RNA polymerase acts as a damage sen-
sor (de Laat et al., 1999; Dogliotti et al., 2001). The result can be
the appearance of a mutation. The consequences of mutations will
differ depending on whether they take place in introns, upstream
sequences, promotors, codifying sequences (exons), etc., since
they will affect the regulation of the amount of RNA expressed,
RNA stability, and the presence of silent or non-silent mutations
in the translated proteins. SSBs can be corrected by various DNA
repair mechanisms, and the DNA damage associated with these
breaks induces p53 target genes to repair DNA (Smith and Seo,
2002).
DNA DSBs are generated throughout cell life and can result in
irreversible damage. To avoid this damage, the cell can generate
a new DNA replicate in order to produce homologous templates
once again (homology-directed repair) (Jones and Petermann,
2012). In the absence of new DNA replication (a feature of
non-dividing cells like neurons), a fast process known as non-
homologous end-joining occurs, which repairs DNA breaks by
shielding the DNA ends (Sale et al., 2012). In proliferating
cells, homology-directed repair is blocked when non-homologous
end-joining is active (Lukas and Lukas, 2013). Also, in sev-
eral neurodegenerative disorders, slippage during replication of
repetitive sequences may occur and thus require repair of the
newly synthesized strand (Schofield and Hsieh, 2003). These
mechanisms are not discussed in this review. However, they
can occur in neurons and do not result in the appearance of
SNVs but in insertions (or deletions) (indels). Neither will we
discuss the regulation of DNA damage responses by ubitiquin
and SUMO (Jackson and Durocher, 2013). Moreover, DNA
damage can arise by reversal apoptosis in a mechanism that
rescues cells from a critical stage named “anastasis” (Tang et al.,
2012).
DNA VARIATIONS IN SOMATIC CELLS
All the above-mentioned processes related to changes in the DNA
sequence of somatic cells may act in a different way in tissues
of different origins. Preliminary results from the comparison
of DNA sequences of exomes from tissues with an endoderm,
mesoderm or exoderm origin support this notion (Gómez-Ramos
et al., 2014). Furthermore, somatic mosaicism has been described
in human skin (Abyzov et al., 2012).
In addition, in the same tissue, for example the central nervous
system, different DNA sequence variations may occur in distinct
cell types.
VARIATIONS IN BRAIN DNA SEQUENCES
Little is known about specific DNA mutations occurring specifi-
cally in brain cells. The adult human brain comprises two main
cell types, neurons and glia cells, in a roughly 50/50 propor-
tion. The main difference between glia cells and neurons is that
the former are proliferating cells that are renewed many times
throughout adult life, while the latter It is assumed that DNA
sequences are conserved in the diverse cell types present in a
multicellular organism like the human being. Thus, in order to
compare the sequences in the genome of DNA from different
individuals, nucleic acid is commonly isolated from a single tissue.
In this regard, blood cells are widely used for this purpose because
of their availability. Thus blood DNA has been used to study
genetic familiar diseases that affect other tissues and organs,
such as the liver, heart, and brain. While this approach is valid
for the identification of familial diseases in which mutations
are present in parental germinal cells and, therefore, in all the
cells of a given organism, it is not suitable to identify sporadic
diseases in which mutations might occur in specific somatic
cells. This review addresses somatic DNA variations in different
tissues or cells (mainly in the brain) of single individuals and
discusses whether the dogma of DNA invariance between cell
types is indeed correct. We will also discuss how single nucleotide
somatic variations arise, focusing on the presence of specific
DNA mutations in the brain.are mainly terminally differenti-
ated, non-dividing cells, usually of the same age as the host
organism.
Some DNA variations (or mutations) can be present in all
the cell types of an organism, as is the case of neurodegenerative
disorders with a familial origin. In these conditions, germinal
cells are responsible for ensuring that the mutations appear in
the DNA of every cell of the organism. Also, if the mutation
takes place in precursor-dividing cells early in development, both
glia and neuron cells carry the same variation in their DNA.
However, when it occurs later during development or in adIt is
assumed that DNA sequences are conserved in the diverse cell
types present in a multicellular organism like the human being.
Thus, in order to compare the sequences in the genome of DNA
from different individuals, nucleic acid is commonly isolated from
a single tissue. In this regard, blood cells are widely used for
this purpose because of their availability. Thus blood DNA has
been used to study genetic familiar diseases that affect other
tissues and organs, such as the liver, heart, and brain. While
this approach is valid for the identification of familial diseases
in which mutations are present in parental germinal cells and,
therefore, in all the cells of a given organism, it is not suitable
to identify sporadic diseases in which mutations might occur
in specific somatic cells. This review addresses somatic DNA
variations in different tissues or cells (mainly in the brain) of
single individuals and discusses whether the dogma of DNA
invariance between cell types is indeed correct. We will also
discuss how single nucleotide somatic variations arise, focusing
on the presence of specific DNA mutations in the brain.ulthood,
this variation may be specific for a cell type or lineage (Figure 1).
Also, in adult cells, somatic DNA variations may be specific for
a cell type, and the mechanism for these variations may differ in
glia and neurons.
LIMITATIONS TO DETECT SNVs IN NEURONAL POPULATIONS
The presence of various cell types in a single tissue hinders
the detection of somatic cell variations using some techniques
(with a low sensitivity), like Sanger’s sequencing. Regarding
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FIGURE 1 | Changes in DNA of germinal and somatic cells.
SNVs in germinal cells, present in the zygote, will result in the
appearance of these SNVs in all the cells of the organism. Changes
resulting in SNVs at earlier developmental stages will be present in
more cells than those occurring in late adulthood. Late somatic
mutations in brain cells may promote specific changes in DNA.
These changes may cause the appearance of neurodegenerative
disorders.
the presence of a DNA mutation in specific cells within brain
tissue, when a mutation is present exclusively in neurons,
a maximum of only 50% of the cells will show the DNA
change; however, when the variation occurs in a specific neu-
ronal population, this percentage is much lower. This scenario
impedes reliable results because dye-terminator sequencing (with
a higher sensitivity) data is usually validated by Sanger’s method
(with a lower sensitivity), which is not suitable for these types
of sample. Moreover, dye-terminator sequencing can generate
errors because of low signal to noise ratios and non- or mis-
detection of the fluorescent signal (Breslow et al., 2008). How-
ever, the problem can be partially solved by increasing the
number of reads of the DNA regions containing the variations
during dye-terminator sequencing. Also, quality filtering tech-
niques may improve Illumina sequencing results (Bokulich et al.,
2013).
One of the major difficulties of making such analysis in living
human brains is that the taking of human samples from brains
must not be done because is a very invasive method. Thus,
samples should be taken from autopsies. On the other hand there
is a high cellular complexity (many cell types). Recently reported
methods of single-cell sequencing are promising for the detection
of individual variations in a single cell but they are not fully
developed, and the extensive PCR-based amplification used in
this method might interfere with the resolution of this approach
(Eberwine et al., 2014).
BRAIN CELLS AND DNA SEQUENCES
During DNA replication in glia cells, erroneous insertions of
a base in the newly synthesized strand, which does not match
the parental strand, can generate a mutation if the mismatch
is not repaired. This type of mutation does not arise in the
case of non-proliferating cells like neurons. In neurons (and also
in glia cells), changes in the DNA sequence can be associated
with other forms of DNA damage. Damage promoted by the
extracellular environment can be solved, or not, depending on
the DNA repair mechanism present in each cell type. These
repair mechanisms involve various proteins, polymerases, ligases,
nucleases, and helicases. Also, small RNAs have been implicated
in DNA repair (Wei et al., 2012), and other factors like ubiquitin
and SUMO may also participate in this process (Ulrich, 2012), as
previously described. Histone ubiquitylation, a process regulated
by various E3 ligases, is a main response to DSBs (Gudjonsson
et al., 2012). The amount of messenger RNAs expressing these
repair proteins in brain cell types differs (see Allen Brain Atlas
(Hawrylycz et al., 2012)). Thus these differences, together with
other distinct transcription levels in different neuronal types, can
result in damage to specific neurons, which may lead to the onset
of neurodegeneration. Indeed, our preliminary data indicate the
presence of a number of SNVs in hippocampal neurons that are
absent in cerebellar neurons (Parcerisas et al., 2014). The DNA
damage response may involve many molecular changes to ensure
correct DNA repair. Some of these changes have been studied in
depth (Beli et al., 2012).
AGING AND OXIDATIVE DAMAGE TO DNA
Aging is a major risk for DNA damage. Aging can bring about
an increase in neuronal DNA lesions (Sedelnikova et al., 2004),
which activate the Ras signaling pathway (Boldogh et al., 2012). In
neurons, it may result in defects in dendritic spine development
and synapse formation (Yang et al., 2013). The damage can be
due, at least in part, to the high levels of reactive oxygen species
(ROS) and the low levels of anti-oxidant defenses in these brain
cells (Finkel and Holbrook, 2000).
ROS-induced DNA damage can lead to the formation of
8-OHdG (see below).
Also, it has been reported that post-mitotic neurons develop a
p21-dependent senescence phenotype driven by a DNA damage
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response (Jurk et al., 2012). On the other hand, it has been found
that DNA methylation declines with age (Heyn et al., 2012).
However, in this short review, we will not address changes in
the epigenome but only briefly comment that chromatin actively
participates in the DNA damage response (Soria et al., 2012).
Although DNA replication takes place in S phase, the DNA
damage response occurs at any point of the cell cycle and in
differentiated, non-proliferating cells like neurons. This response
occurs in the context of chromatin in eukaryotic cells, where DNA
is wrapped with histone proteins, and there are some variations
in proteins, like H2A-X, whose phosphorylation is increased in
the DNA damage response (Hiller et al., 2012).
The DNA damage response is characterized by the activation
of a kinase such as H2A-X (as previously indicated), which
modifies histones, or by the induction of proteins like p53 or
p21, which contribute to cell cycle arrest. Also, the acetylation of
some proteins is involved in this response (Robert et al., 2011),
and specific acetylation of p53 by HDAC inhibition prevents
DNA damage in neurons (Brochier et al., 2013). Furthermore,
DNA damage, mainly in the form of DSBs, may lead to cellular
senescence.
Regarding new neuronal cells, adult neurogenesis requires a
stringent genomic maintenance program to ensure the correct
transmission of the genetic program to newborn neurons. A fac-
tor in this program is TopBP1, a protein linked to DNA replication
that is essential for the maintenance of genome integrity during
the proliferation of neuronal precursors. A failure in this protein
may promote a modification of DNA in the affected neuronal
precursors (Lee et al., 2012). Also, regarding transposons, it has
been reported that some small RNAs trigger the formation of
a class of small RNAs that silence transposon targets (Xiol and
Pillai, 2012).
More recently, it has been described that brain activity causes
DNA DSBs in neurons and that these breaks are exacerbated by
the presence of amyloid beta (Suberbielle et al., 2013). It is not
clear yet whether this exacerbation is due to an increase in the
transcription of specific genes.
MECHANISMS FOR DNA SEQUENCE VARIATIONS IN BRAIN
Neuron DNA damage, resulting in the appearance of SNVs, can
favor neurodegeneration and cognitive decline in diseases like AD
(Brasnjevic et al., 2008; Moreira et al., 2008; Suberbielle et al.,
2013).
These SNVs are present after DNA opening, DNA damage,
and/or inefficient repair. Opening of the DNA double helix occurs
by two mechanisms, namely DNA replication and DNA tran-
scription. Various proteins, present in different amounts, related
to DNA replication transcription or reparation are expressed in
neurons and glia cells, as clearly indicated in the Allen Brain
Atlas (Hawrylycz et al., 2012). For neurons, the opening of the
helix takes place during transcription. Gene expression in the
adult mammalian brain is complex. It has been suggested that
at least 80% of all genes are expressed in the central nervous
system (Lein et al., 2007; Hawrylycz et al., 2012). For glia, DNA
opening occurs during both DNA replication and transcription.
It has been hypothesized that transcription may be involved
mainly in the appearance of DNA variations in neuronal cells,
FIGURE 2 | SNVs in neuron and glia. Possible relationship with DNA
transcription or DNA replication. Percentage of genes with at least one SNV
expressed in hippocampal neuron and glial cells (Parcerisas et al., 2014) that
are translated into proteins according to the expression levels provided by
the database The Human Protein Atlas.1 The levels of expression of the
first 200 genes containing the most hippocampal-specific SNVs (according
to a Fisher test respect to the SNVs found in blood), as shown by
immunological detection, were checked one by one in the database and
their expression in this tissue was annotated.
late in development or in the adult organism. We have been
examining the SNVs of 200 genes in hippocampal tissue (see
legend of Figure 2). Based on the data of the Human Protein
Atlas and on the basis of the transcription/translation level of
these genes, we have divided them into high, moderate, low,
or undetected expression. Thus, we have tested the percentage
of SNVs in genes expressed at different levels in neurons and
glia cells. We found a higher percentage of DNA changes in
cells with high expression of neuronal genes than those with
low expression (Figure 2). These observations point to a greater
relationship between transcription level and DNA damage in
neuronal cells, while DNA damage in glia cells is caused mainly
by DNA replication.
Regarding a possible relation between DNA transcription and
DNA damage, a ubiquitin-driven link between gene expression
and the DNA damage response has been put forward (Shiloh et al.,
2011). On the other hand, the presence of DNA loops during
transcription may facilitate oxidation, mainly of deoxyguanosine,
by ROS (Cadet et al., 1997), yielding the formation of 8-OHdG.
Indeed, it has been proposed that oxidative DNA damage initiates
neurodegenerative diseases (Perry et al., 2001). In this regard, the
damage is not exerted only at the DNA molecule, but unassem-
bled DNA bases can also be oxidized, and these modified bases can
be misincorporated into DNA (Luo et al., 2010). However, there is
a mechanism—through the enzyme MTH1—that hydrolyzes oxi-
dized DNA bases, thus preventing misincorporation (Dominissini
and He, 2014).
VARIATIONS IN NEURON DNA AMOUNT AND SEQUENCES
AND THEIR POSSIBLE ASSOCIATION WITH NEUROLOGICAL
DISEASES
Although most neurons are diploid, a small population of these
cells surpasses the diploid level (Fischer et al., 2012). These
hyperploid neurons are selectively affected by cell death at early
1http://www.proteinatlas.org/
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stages of AD (Arendt et al., 2010). More recently, an increase in
X chromosome aneuploidy has been reported in brain cells of
female AD patients (Sugiyama et al., 2014).
By testing DNA from hippocampus, researchers recently
revealed the presence of SNVs or insertions/deletions (indels)
in AD patients but not in demented controls (Parcerisas et al.,
2014). Little is known about the mechanism underlying indels,
although a process similar to that of RNA-guided human genome
engineering via cas9 has been proposed (Cho et al., 2013; Mali
et al., 2013). However, whether this type of mechanism takes
place in aging or in AD remains to be elucidated. Finally,
transposons are found in brain DNA (Singer et al., 2010;
Vogel, 2011), although no association has been made with AD.
In addition, aging and AD are characterized by a decreased
capacity for DNA repair as a result of a reduction in DNA
end-joining activity (a process that calls for DNA-dependent
protein kinase activity) required to repair DSBs (Kanungo,
2013).
VARIATIONS IN DNA SEQUENCES OF BRAIN CELLS
OBTAINED FROM AD PATIENTS
The most predominant neurodegenerative disorder is AD
(Selkoe, 2011). This disease has been divided into two types,
the familial type of predominantly early onset, and the sporadic
type, with no familial association, of later onset (Bertram et al.,
2010). For familial cases (FAD), genome sequence analysis of
DNA from the patients’ lymphocytes have indicated that the
disease is caused by mutations in three genes (APP, PS-1 and
PS-2) (Selkoe, 2011). To look for possible genetic risk factors in
sporadic AD (SAD), genome-wide association studies (GWAS)
have been carried out in patients with this disease (Manolio et al.,
2009; Lambert et al., 2013; Ridge et al., 2013; Zhang et al., 2013),
also using DNA from lymphocytes. Also, a higher frequency of
DNA damage in blood lymphocytes of SAD patients compared
with age-matched controls has been reported (Zivkovic´ et al.,
2013). This observation could be attributable to the presence of a
different DNA damage repair mechanism (Leandro et al., 2013).
Early work revealed that the e4 allele of APOE is a strong
risk factor for AD. Other risk factors include the presence of
SNVs as specific sequences in genes like: ABCS7, BIN1, CD33,
CD2AP, CLU, CR1, EPHA1, MS4A4E/MS4A6A, PICALM and
SORL1 (Schellenberg and Montine, 2012). In addition, two new
susceptibility genes for AD have been reported (Escott-Price et al.,
2014), and recently an AD-associated polymorphism in human
OGG1 that sensitizes cells to DNA damage has been described
(Jacob et al., 2013).
However, a significant proportion of the possible genetic
defects related to the development of SAD remains unexplained.
This missing defect has been named the “dark matter” of GWAS
(Manolio et al., 2009), in an attempt to explain the “missing
heritability” by means of GWAS analysis using DNA from lym-
phocytes (Manolio et al., 2009). Furthermore, little has been
reported about the presence of a specific type of mutation,
through insertions or deletions (indels), in AD.
Our hypothesis is that some genetic defects of SAD are present
only in somatic mutations in neurons but not in peripheral cells
like lymphocytes or in the germ line, as is the case for FAD
patients (Figure 1). These somatic defects, which are specific to
neuronal tissue, are postulated to favor the appearance of late
onset dementia in SAD patients.
Preliminary data have indicated the presence of specific
mutations in brain tissue from AD patients that are not present in
the blood of these patients (Parcerisas et al., 2014). The proteins
expressed by these brain genes include transcription factors, ion
channels, and proteins related to lipid transport and metabolism,
to the cytoskeleton, etc. . . The possible relation between
variations in these genes and neurological disorders deserves
further attention. Although mainly non-silent exome DNA
variations have been characterized, the analysis of silent exome
DNA SNVs could also be of interest due to the consequences of
the codon bias in gene expression (Plotkin and Kudla, 2011).
ROLE OF BETA AMYLOID AND TAU PROTEIN IN DNA
DAMAGE
About a century ago, Alzheimer described the presence of two
aberrant structures, senile plaques and neurofibrillary tangles, in
the brain of a demented patient (Alzheimer, 1907). We now know
that the main component of the plaques is beta amyloid peptide
and that of tangles is tau protein.
It has been proposed that Aβ peptide exerts DNA nicking
activity that promotes DNA damage and that such damage may
occur in AD patients (Gupta et al., 2013). Brain activity causes
DNA DSBs in neurons, and these breaks are exacerbated by
amyloid-β (Suberbielle et al., 2013). It has recently been shown
that NAD attenuates oxidative DNA damage induced by Aβ
peptide in cultured cortical neurons (Wu et al., 2014).
Furthermore, mutations in the MAPT gene cause chromo-
some instability and can introduce copy number variation in
the genome (Rossi et al., 2013) (see also ref Rossi et al., 2008).
Tau protein is not only a cytoskeletal protein but it is found in
the nucleus of neurons (Wang et al., 1993; Brady et al., 1995;
Lambert et al., 1995; Sultan et al., 2011). Indeed, tau is a DNA-
binding protein (Corces et al., 1980; Krylova et al., 2005; Wei
et al., 2008; Camero et al., 2014) and it plays a major role in
neuronal DNA protection (Violet et al., 2014). Also it has been
described that a high level of cytoplasm tau protein promotes neu-
rodegeneration via DNA damage, heterochromatin relaxation,
and piwi-like RNA-mediated gene silencing 1 (PIWIL-1), thus
facilitating cell cycle re-entry (Frost et al., 2014). The differences
between the two effects exerted by tau can be explained by its form
and distribution. Dephosphorylated tau localizes in the nucleus,
playing a protective role. In contrast, phosphorylated tau, present
in the cytoplasm, interacts with mitochondrial protein DRP1,
impairing mitochondrial function and facilitating the production
of ROS and DNA damage (DuBoff et al., 2012; Manczak and
Reddy, 2012; Camero et al., 2014).
In summary, brain-specific DNA changes occur. Thus brain
DNA rather than blood DNA should be used to analyze somatic
DNA variations linked to neurological diseases and present in
brain cells.
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